aid: accurateinternational
name: Accurate International
description: >-
  Accurate International Biotechnology (trading as ACCURATE, 广州创芯国际生物科技有限公司) is a
  Guangzhou, China biotechnology company founded in 2018 that builds the full industry chain
  around organoid technology for cancer precision medicine, new drug research and regenerative
  medicine. Its products are wet-lab reagents, instruments and consumables rather than software:
  Accuroid organoid culture media, the AccuArray microarray organoid chip, the AOMF microfluidic
  organoid chip and 3D bioprinter, the AccuLumi high-throughput chemiluminescence detector, and
  Accuauto automated organoid culture workstations. On top of those it sells services — BUDcare
  and BUDhealth patient-derived tumor organoid drug-sensitivity testing delivered through
  Guangzhou Chuangxin Independent Clinical Laboratory, and organoid-model new-drug R&D services
  for pharma — and reports 32,000+ organoid cultures, 5,000+ tumor organoid models, 200+ clinical
  collaborators and 100+ filed patents. It holds subsidiaries in Beijing, Shanghai and Macau plus
  a European entity, and has raised Pre-A (2020), Series A (2021), a 100M RMB Pre-B (2022) and a
  Series B (2024). ACCURATE describes internal digital assets — the AOD Tronchip organoid
  database launched in 2023 and a cancer "deep-thinking" AI model built in 2024 — but publishes
  no developer portal, API reference, SDK, CLI, status page or public GitHub organization, and no
  OpenAPI, AsyncAPI, GraphQL, MCP or A2A agent-card surface was found on any host it operates.
url: https://raw.githubusercontent.com/api-evangelist/accurateinternational/refs/heads/main/apis.yml
image: https://en.bio-accurate.com/dist/images/logo.png
x-type: company
x-source: harvest:secondary-market
x-harvest-source-url: https://equityzen.com/company/accurateinternational
x-venue-listings:
- venue: EquityZen
  url: https://equityzen.com/company/accurateinternational
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-09-06'
modified: '2026-09-06'
tags:
- Company
- Biotechnology
- Life Sciences
- Precision Medicine
- Oncology
- Organoids
- Laboratory Instruments
- Clinical Diagnostics
- Drug Discovery
- China
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/accurateinternational-domain-security.yml
- type: Website
  url: https://en.bio-accurate.com/
- type: Blog
  url: https://en.bio-accurate.com/news/dynamic/
- type: LLMsTxt
  url: llms/accurateinternational-llms.txt
x-enrichment:
  date: '2026-09-06'
  status: minimal
  artifacts_added: 3
  pass: local-v3
x-coverage:
  state: none
  reason: no-developer-program
  detail: >-
    ACCURATE is a Guangzhou organoid biotech selling culture media, microfluidic chips,
    detectors and clinical drug-sensitivity testing — its only digital assets (the AOD
    Tronchip organoid database and a 2024 cancer AI model) are internal R&D tooling with no
    public interface, and bio-accurate.com has no developer section, no /.well-known/
    documents on either host, and no api/db/data/developer subdomain in DNS.
  evidence:
  - url: https://en.bio-accurate.com/
    status: 200
  - url: https://en.bio-accurate.com/.well-known/agent-card.json
    status: 404
  - url: https://en.bio-accurate.com/.well-known/api-catalog
    status: 404
  - url: https://www.bio-accurate.com/.well-known/security.txt
    status: 404
  checked: '2026-09-06'